Omnix Medical Ltd.

Omnix Medical Ltd.

Private
JerusalemHealthcare & Life Scienceshttps://omnixmedical.com/

Last Round

Series C

Oct 15, 2025

Total Funding Raised

$73.1M

Company Overview

Omnix Medical Ltd. is a biopharmaceutical company that develops next-generation antimicrobial peptides to treat drug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

antimicrobial resistanceAMRantimicrobial peptidessuperbugsmulti-drug resistanceanti-infective agentshospital-acquired infectionsantibiotic alternativesGram-negative bacteriapeptide therapeuticsventilator-associated pneumoniaVABPhospital-acquired pneumoniaHABPAcinetobacter baumanniinosocomial infectionsHAIQualified Infectious Disease ProductQIDPFDA Fast-Track

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omnix Medical Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Omnix Medical Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series COct 15, 2025
Series COct 15, 2025
GrantJan 25, 2021
Series ANov 20, 2020
SeedDec 1, 2018

Key People

Founding team and executive leadership

Moshik Cohen-Kutner

Co Founder CEO

Founding Team

Omnix Medical Ltd. Investors

Notable investors and investment history

Omnix Medical Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Omnix Medical Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Omnix Medical Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJerusalem
Employee Range27
Year Founded2015
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.